Harris fait l’acqusition du portefeuille de produits i2 d’IBM

OTTAWA, Ontario, et CAMBRIDGE, Royaume-Uni, 05 janv. 2022 (GLOBE NEWSWIRE) — Harris, un fournisseur mondial de logiciels sur le marché vertical, a fait l’acquisition du portefeuille de produits d’analyse du renseignement i2 d’IBM, y compris les plateformes i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) et i2 iBase. Cette acquisition […] Lire la suite »

Harris erwirbt i2-Produktportfolio von IBM

OTTAWA, Ontario und CAMBRIDGE, Großbritannien, Jan. 05, 2022 (GLOBE NEWSWIRE) — Harris, ein globaler Softwareanbieter für vertikale Märkte, hat das i2-Produktportfolio für nachrichtendienstliche Analysen von IBM, einschließlich der Plattformen i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) und i2 iBase, erworben. Durch den Erwerb wird Harris in die Lage versetzt, […] Lire la suite »

Calibre Mining Shareholders Overwhelmingly Approve Fiore Gold Acquisition

VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce that at a special meeting of shareholders held earlier today (the “Meeting”), Calibre shareholders voted overwhelmingly in favour of the resolution (the “Calibre Shareholder Resolution”) approving […] Lire la suite »

Expereo nomme Ben Elms au poste de responsable des recettes

AMSTERDAM, Pays-Bas, 05 janv. 2022 (GLOBE NEWSWIRE) — Expereo, le plus grand fournisseur au monde de services mondiaux de connectivité Internet, d’optimisation de l’accès au Cloud, de SASE et de SD-WAN, a annoncé aujourd’hui la nomination de Ben Elms au poste de responsable des recettes. La mission globale de M. […] Lire la suite »

Expereo ernennt Ben Elms zum Chief Revenue Officer

AMSTERDAM, Niederlande, Jan. 05, 2022 (GLOBE NEWSWIRE) — Expereo, der weltweit führende Anbieter von globalen Internet-, Cloudzugriffsoptimierungs-, SASE- und SD-WAN-Diensten, hat heute die Ernennung von Ben Elms zum Chief Revenue Officer bekannt gegeben. Die übergreifende Aufgabe von Elms besteht darin, die Transformation des Vertriebs und der Markteinführung in allen Kanälen […] Lire la suite »

Onica, A Rackspace Technology Company, Announces AWS Emissions Monitoring and Surveillance Solution Deployment Partnership

SAN ANTONIO, Jan. 05, 2022 (GLOBE NEWSWIRE) — Onica by Rackspace Technology, the Amazon Web Services (AWS) focused business group of Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company, today announced its deployment relationship with AWS on Emissions Monitoring and Surveillance (EMS). EMS is a new solution […] Lire la suite »

VinFast Launches VinFirst NFT for EV’s Early-Bird Reservation

LOS ANGELES, Jan. 05, 2022 (GLOBE NEWSWIRE) — VinFast, the global electric vehicle (EV) brand owned by Vingroup – the largest private conglomerate in Vietnam with a total capitalization of 34.9 billion USD from three publicly traded companies (as of Nov 3, 2021) – has partnered with AAG Ventures and […] Lire la suite »

Neeyamo Has Been Recognized as an Innovator in Avasant’s Global Hire-to-Retire Business Process Transformation 2021-22 RadarView

LOS GATOS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Neeyamo Inc., a leading technology-enabled global payroll and HR services provider for multinational and micro-multinational corporations worldwide, has been recognized as an Innovator in Avasant’s maiden Global Hire-to-Retire Business Process Transformation 2021-22 RadarView. Avasant is a management consulting firm specializing in […] Lire la suite »

F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, today announced that Ares Trading S.A., an affiliate of Merck KGaA, Darmstadt, Germany has […] Lire la suite »

T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel

SAN FRANCISCO, Jan. 05, 2022 (GLOBE NEWSWIRE) — T-knife Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, today announced the appointment of Ronald Krasnow, J.D., who brings over thirty years of legal counsel and executive management experience to T-knife. “I am pleased to welcome Ron […] Lire la suite »

Gentex to Showcase Driver & Cabin Monitoring at CES 2022

LAS VEGAS, Jan. 05, 2022 (GLOBE NEWSWIRE) — In-person CES is back and so is Gentex Corporation (NASDAQ: GNTX), which will once again exhibit at the event to highlight its growing driver and in-cabin monitoring solutions for the automotive industry, as well as demonstrate its ever-expanding portfolio of vision systems, […] Lire la suite »

Elemica CEO Recognized as one of the best CEOs of 2021

PHILADELPHIA, Jan. 05, 2022 (GLOBE NEWSWIRE) — Elemica’s receipt of a third Comparably award reinforces that strong leadership has positioned this company for a successful future. “Elemica excels at creating powerful connections within organization’s supply chains,” Elemica CEO David Muse commented. “Providing our clients with a top tier service starts […] Lire la suite »

A2Mac1 est heureux de recevoir le trophée « Vitrine Industrie du Futur »

Hary, 5 janvier 2022: A2Mac1 a reçu aujourd’hui le trophée « Vitrine Industrie du Futur », label d’excellence de La French Fab, remis par Frédéric Motte Conseiller Régional et délégué à la transformation économique et Président de la mission REV3, accompagné de Nelly Janier-Dubry et Eric Donnay, Conseillers Régionaux Hauts-de-France. Ce label […] Lire la suite »

Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module

SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biociences Co., Ltd (“Junshi Biosciences”, HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and DotBio Pte. Ltd (“DotBio”), a biotech company specialized in next generation antibody therapies, […] Lire la suite »

Conagen Successfully Develops Antioxidant Kaempferol by Precision Fermentation

Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing commercially valuable molecules for its partners and clients, Conagen’s kaempferol enables brands in nutrition, beauty, and personal […] Lire la suite »

Covis achève l’acquisition du portefeuille de produits respiratoires mondial de deux médicaments auprès d’AstraZeneca

ZOUG, Suisse, 05 janv. 2022 (GLOBE NEWSWIRE) — Covis Pharma Group (« Covis »), une société pharmaceutique spécialisée d’envergure internationale qui commercialise des solutions thérapeutiques pour les patients atteints de troubles chroniques et de maladies potentiellement mortelles, a annoncé aujourd’hui que Covis Pharma GmbH avait achevé l’acquisition auprès d’AstraZeneca (l’« acquisition ») d’Eklira® (bromure […] Lire la suite »

Covis schließt Übernahme eines globalen Atemwegsportfolios mit zwei Medikamenten von AstraZeneca ab

ZUG, Schweiz, Jan. 05, 2022 (GLOBE NEWSWIRE) — Die Covis Pharma Group („Covis“), ein globales spezialisiertes Pharmaunternehmen, das therapeutische Lösungen für Patienten mit lebensbedrohlichen und chronischen Erkrankungen vertreibt, gab heute bekannt, dass die Covis Pharma GmbH die Übernahme von Eklira® (Aclidiniumbromid), das in den USA unter dem Namen Tudorza® bekannt ist und in einigen […] Lire la suite »